Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 967 | 967 | 751 | 607 | 1156 | 2401 |
Fund Return | -3.3% | -3.3% | -24.9% | -15.33% | 2.94% | 9.16% |
Place in category | 841 | 841 | 1134 | 982 | 626 | 162 |
% in Category | 52 | 52 | 78 | 85 | 74 | 42 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Lion Growth Fund | 16.77B | -10.89 | -10.56 | 3.58 | ||
Lion Equity Fund | 3.74B | -8.67 | 0.07 | 10.71 | ||
Lion Positive Return Alloc Fd | 3.34B | 24.65 | 0.95 | - | ||
Lion Gr Sel Ret Mixed Fd | 1.84B | -7.08 | 7.82 | - | ||
Lion New Economy Eq | 1.18B | 0.07 | -5.23 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fullgoal Tianhui Selected Growth Mi | 27.72B | -0.58 | -11.51 | 11.85 | ||
Industrial Herun Structured Mixed S | 21.7B | -3.95 | -13.18 | 15.76 | ||
Industrial Trend Investment Hybrid | 15.62B | 0.18 | -13.45 | 10.92 | ||
IGW DingYi(LOF) | 12.28B | -0.78 | -13.32 | 15.12 | ||
Industrial Business Model Select In | 10.9B | -2.06 | -8.11 | 17.37 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Beijing Balance Medical Technology Co | CNE100005X15 | 8.67 | 117.86 | -0.67% | |
Wuliangye A | CNE000000VQ8 | 8.61 | 154.96 | -0.63% | |
Eyebright Medical Technology Beijing | CNE1000041J5 | 6.34 | 149.80 | -0.90% | |
Imeik | CNE100004868 | 6.02 | 217.00 | -2.13% | |
Changchun BCHT Biotechnology | CNE100005XY6 | 5.50 | 40.84 | -0.80% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Neutral | Sell |
Technical Indicators | Strong Buy | Strong Buy | Strong Sell |
Summary | Strong Buy | Buy | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review